{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T15:38:17Z","timestamp":1763480297815,"version":"3.44.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Pr\u00f3-reitoria de P\u00f3s-Gradua\u00e7\u00e3o e Pesquisa"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.bbr.2019.112119","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T14:00:26Z","timestamp":1564495226000},"page":"112119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Influence of magnesium supplementation and L-type calcium channel blocker on haloperidol-induced movement disturbances"],"prefix":"10.1016","volume":"374","author":[{"given":"Maikel","family":"Kronbauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinicia Garzela","family":"Metz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Roversi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura H.","family":"Milanesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenika","family":"Rubert Rossato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel Cristine","family":"da Silva Barcelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilise E.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2019.112119_bib0005","first-page":"S113","article-title":"Tardive dyskinesia syndromes: current concepts, Parkinsonism Relat","volume":"20","author":"Aquino","year":"2014","journal-title":"Disord."},{"key":"10.1016\/j.bbr.2019.112119_bib0010","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/JCP.0b013e3181f14098","article-title":"Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia: thirty-six-month results from the European schizophrenia outpatient health outcomes study","volume":"30","author":"Novick","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbr.2019.112119_bib0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ncl.2014.09.011","article-title":"Drug-induced movement disorders","volume":"33","author":"Mehta","year":"2015","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.bbr.2019.112119_bib0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/schbul\/sbq042","article-title":"Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons","volume":"38","author":"Rummel-Kluge","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbr.2019.112119_bib0025","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1192\/bjp.bp.111.101485","article-title":"Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs","volume":"200","author":"Peluso","year":"2012","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.bbr.2019.112119_bib0030","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.4088\/JCP.16r10832","article-title":"Tardive dyskinesia prevalence in the period of second-generation antipsychotic use","volume":"78","author":"Carbon","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbr.2019.112119_bib0035","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brainres.2004.10.038","article-title":"Acute reserpine and subchronic haloperidol treatments\u202fchange synaptosomal brain glutamate uptake and elicit orofacial dyskinesia in rats","volume":"1031","author":"Burger","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2019.112119_bib0040","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF03033914","article-title":"Ilex paraguariensis has antioxidant potential and attenuates haloperidol-induced orofacial dyskinesia and memory dysfunction in rats","volume":"12","author":"Colpo","year":"2007","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bbr.2019.112119_bib0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.brainresbull.2006.05.002","article-title":"Effects of diphenyl-diselenide on orofacial dyskinesia model in rats","volume":"70","author":"Burger","year":"2006","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbr.2019.112119_bib0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pnpbp.2016.08.010","article-title":"Lipoic acid and haloperidol-induced vacuous chewing movements: implications for prophylactic antioxidant use in tardive dyskinesia","volume":"72","author":"Lister","year":"2017","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry."},{"key":"10.1016\/j.bbr.2019.112119_bib0055","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2147\/NDT.S30767","article-title":"Treatment of neurolept-induced tardive dyskinesia","volume":"9","author":"Jankelowitz","year":"2013","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.bbr.2019.112119_bib0060","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.pnpbp.2007.06.028","article-title":"Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: role of dopamine transporter","volume":"31","author":"Fachinetto","year":"2007","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry."},{"key":"10.1016\/j.bbr.2019.112119_bib0065","doi-asserted-by":"crossref","DOI":"10.1177\/0706743719828968","article-title":"Treatment recommendations for tardive dyskinesia","author":"Ricciardi","year":"2019","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.bbr.2019.112119_bib0070","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/YCO.0000000000000491","article-title":"Antipsychotic-induced tardive dyskinesia: update on epidemiology and management","volume":"32","author":"Widschwendter","year":"2019","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.bbr.2019.112119_bib0075","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/mds.27630","article-title":"Tardive dyskinesia is associated with altered putamen Akt\/GSK\u20103\u03b2 signaling in nonhuman primates","volume":"34","author":"Hernandez","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2019.112119_bib0080","first-page":"1","article-title":"Pharmacogenetics of tardive dyskinesia in schizophrenia: the role of CHRM1 and CHRM2 muscarinic receptors","author":"Boiko","year":"2019","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2019.112119_bib0085","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bbr.2016.10.049","article-title":"Influence of magnesium supplementation on movement side effects related to typical antipsychotic treatment in rats","volume":"320","author":"Kronbauer","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2019.112119_bib0090","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12011-015-0268-9","article-title":"Magnesium Supplementation Prevents and Reverses Experimentally Induced Movement Disturbances in Rats: Biochemical and Behavioral Parameters","volume":"166","author":"Kronbauer","year":"2015","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.bbr.2019.112119_bib0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/000456329102800103","article-title":"The role of magnesium in clinical biochemistry: an overview","volume":"28","author":"Ryan","year":"1991","journal-title":"Rev. Artic. Ann Clin Biochem."},{"key":"10.1016\/j.bbr.2019.112119_bib0100","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/bja\/83.2.302","article-title":"Magnesium: physiology and pharmacology","volume":"83","author":"Fawcett","year":"1999","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.bbr.2019.112119_bib0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/00365519409095206","article-title":"Introduction: importance of Mg in physiology and medicine and the need for ion selective electrodes","volume":"217","author":"Altura","year":"1994","journal-title":"Scand. J. Clin. Lab. Invest. Suppl."},{"key":"10.1016\/j.bbr.2019.112119_bib0110","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0002-8703(84)90572-6","article-title":"Magnesium: nature\u2019s physiologic calcium blocker","volume":"108","author":"Iseri","year":"1984","journal-title":"Am. Heart J."},{"key":"10.1016\/j.bbr.2019.112119_bib0115","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.neuropharm.2011.12.029","article-title":"Influence of external magnesium ions on the NMDA receptor channel block by different types of organic cations","volume":"62","author":"Nikolaev","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2019.112119_bib0120","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brainres.2010.03.076","article-title":"Magnesium supplementation enhances the anticonvulsant potential of valproate in pentylenetetrazol-treated rats","volume":"1334","author":"Safar","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2019.112119_bib0125","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1179\/174313209X385617","article-title":"Effect of magnesium, MK-801 and combination of magnesium and MK-801 on blood-brain barrier permeability and brain edema after experimental traumatic diffuse brain injury","volume":"31","author":"Imer","year":"2009","journal-title":"Neurol. Res."},{"key":"10.1016\/j.bbr.2019.112119_bib0130","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.mehy.2009.10.051","article-title":"Magnesium for treatment-resistant depression: a review and hypothesis","volume":"74","author":"Eby","year":"2010","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.bbr.2019.112119_bib0135","doi-asserted-by":"crossref","first-page":"8199","DOI":"10.3390\/nu7095388","article-title":"Magnesium in prevention and therapy","volume":"7","author":"Gr\u00f6ber","year":"2015","journal-title":"Nutrients."},{"key":"10.1016\/j.bbr.2019.112119_bib0140","first-page":"49","article-title":"Magnesium in health and disease","volume":"13","author":"Romani","year":"2013","journal-title":"Met. Ions Life Sci."},{"key":"10.1016\/j.bbr.2019.112119_bib0145","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.neuropharm.2011.07.027","article-title":"Magnesium deficiency induces anxiety and HPA axis dysregulation: modulation by therapeutic drug treatment","volume":"62","author":"Sartori","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2019.112119_bib0150","first-page":"929","article-title":"Gating of dopamine transmission by calcium and axonal N-, Q-, T- and L-type voltage-gated calcium channels differs between striatal domains","volume":"593","author":"Brimblecombe","year":"2015","journal-title":"J. Physiol. (Paris)"},{"key":"10.1016\/j.bbr.2019.112119_bib0155","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ceca.2012.04.011","article-title":"Ca(2+) channels and transmitter release at the active zone","volume":"52","author":"Schneggenburger","year":"2012","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bbr.2019.112119_bib0160","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1042\/BST0340903","article-title":"Role of voltage-gated L-type Ca2+ channel isoforms for brain function","volume":"34","author":"Striessnig","year":"2006","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbr.2019.112119_bib0165","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/cne.21567","article-title":"Ultrastructural evidence for pre- and postsynaptic localization of Cav1.2 L-type Ca2+ channels in the rat hippocampus","volume":"506","author":"Tippens","year":"2008","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.bbr.2019.112119_bib0170","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4161\/chan.5.5.16473","article-title":"Signaling complexes of voltage-gated calcium channels","volume":"5","author":"Turner","year":"2011","journal-title":"Channels Austin (Austin)"},{"key":"10.1016\/j.bbr.2019.112119_bib0175","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.nbd.2011.04.007","article-title":"The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson\u2019s disease","volume":"43","author":"Ilijic","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbr.2019.112119_bib0180","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1002\/mds.22801","article-title":"A molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson\u2019s disease","volume":"25","author":"Chan","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2019.112119_bib0185","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.nbd.2010.08.020","article-title":"L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer\u2019s disease","volume":"41","author":"Anekonda","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbr.2019.112119_bib0190","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10059-011-0075-x","article-title":"Effects of amyloid-\u03b2 peptides on voltage-gated L-type Ca(V)1.2 and Ca(V)1.3 Ca(2+) channels","volume":"32","author":"Kim","year":"2011","journal-title":"Mol. Cells"},{"key":"10.1016\/j.bbr.2019.112119_bib0195","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000206.pub4","article-title":"Calcium channel blockers for antipsychotic-induced tardive dyskinesia","author":"Essali","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbr.2019.112119_bib0200","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s11064-008-9660-6","article-title":"Protective effect of L-type calcium channel blockers against haloperidol-induced orofacial dyskinesia: a behavioural, biochemical and neurochemical study","volume":"33","author":"Bishnoi","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbr.2019.112119_bib0205","article-title":"Effects of combined therapy with nifedipine and melatonin on haloperidol- induced tardive dyskinesia in rats","volume":"3","author":"Abdel-raheem","year":"2010","journal-title":"Asian J. Pharm. Clin. Res."},{"key":"10.1016\/j.bbr.2019.112119_bib0210","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brainres.2004.10.038","article-title":"Acute reserpine and subchronic haloperidol treatments change synaptosomal brain glutamate uptake and elicit orofacial dyskinesia in rats","volume":"1031","author":"Burger","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2019.112119_bib0215","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.pbb.2005.05.002","article-title":"Ebselen attenuates haloperidol-induced orofacial dyskinesia and oxidative stress in rat brain","volume":"81","author":"Burger","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"year":"2013","series-title":"The Rat Brain in Stereotaxic Coordinates: Hard Cover Edition","author":"Paxinos","key":"10.1016\/j.bbr.2019.112119_bib0220"},{"key":"10.1016\/j.bbr.2019.112119_bib0225","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0006-2952(93)90530-A","article-title":"Ion transport ATPases as targets for free radical damage","volume":"46","author":"Rohn","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbr.2019.112119_bib0230","series-title":"Full Papers","first-page":"608","author":"Trevisan","year":"2009"},{"key":"10.1016\/j.bbr.2019.112119_bib0235","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbr.2019.112119_bib0240","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.fct.2017.09.048","article-title":"Toxicological aspects of the interesterified-fat from processed foods: influences on opioid system and its reward effects in rats","volume":"110","author":"Milanesi","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bbr.2019.112119_bib0245","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neulet.2017.09.066","article-title":"The plasma membrane calcium pumps\u2014the old and the new","volume":"663","author":"Zaidi","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbr.2019.112119_bib0250","doi-asserted-by":"crossref","DOI":"10.4331\/wjbc.v1.i9.271","article-title":"Plasma membrane Ca 2+ -ATPases: targets of oxidative stress in brain aging and neurodegeneration","author":"Zaidi","year":"2010","journal-title":"World J. Biol. Chem."},{"key":"10.1016\/j.bbr.2019.112119_bib0255","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.neuint.2006.09.015","article-title":"Haloperidol induces neurotoxicity by the NMDA receptor downstream signaling pathway, alternative from glutamate excitotoxicity","volume":"50","author":"Zhuravliova","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbr.2019.112119_bib0260","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bbr.2011.02.026","article-title":"Comparative study between two animal models of extrapyramidal movement disorders: prevention and reversion by pecan nut shell aqueous extract","volume":"221","author":"Trevizol","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2019.112119_bib0265","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.brainres.2011.07.014","article-title":"Alpha-phenyl-N-tert-butylnitrone prevents oxidative stress in a haloperidol-induced animal model of tardive dyskinesia: investigating the behavioural and biochemical changes","volume":"1412","author":"Daya","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2019.112119_bib0270","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF03033914","article-title":"Ilex paraguariensis has antioxidant potential and attenuates haloperidol-induced orofacial dyskinesia and memory dysfunction in rats","volume":"12","author":"Colpo","year":"2007","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bbr.2019.112119_bib0275","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.neuropharm.2010.10.017","article-title":"Beneficial effects of an innovative exercise model on motor and oxidative disorders induced by haloperidol in rats","volume":"60","author":"Teixeira","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2019.112119_bib0280","first-page":"389","article-title":"Neurobiological basis of dyskinetic effects induced by antipsychotics: the contribution of animal models","volume":"20","author":"Creed","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbr.2019.112119_bib0285","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1007\/s00213-014-3582-6","article-title":"Oxidative stress and the antipsychotic-induced vacuous chewing movement model of tardive dyskinesia: evidence for antioxidant-based prevention strategies","volume":"231","author":"Lister","year":"2014","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2019.112119_bib0290","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0028-3908(03)00101-1","article-title":"Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia","volume":"44","author":"Naidu","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2019.112119_bib0295","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061442","article-title":"NMDA Receptor Model of Antipsychotic Drug-Induced Hypofrontality","volume":"20","author":"Krzystanek","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbr.2019.112119_bib0300","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.euroneuro.2008.06.005","article-title":"Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology","volume":"18","author":"Paz","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2019.112119_bib0305","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ceca.2012.04.015","article-title":"Mitochondrial Ca2+ and neurodegeneration","volume":"52","author":"Cal\u00ec","year":"2012","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bbr.2019.112119_bib0310","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ceca.2010.01.003","article-title":"Calcium, ischemia and excitotoxicity","volume":"47","author":"Szydlowska","year":"2010","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bbr.2019.112119_bib0315","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1271\/bbb.120671","article-title":"Combined low calcium and lack magnesium is a risk factor for motor deficit in mice","volume":"77","author":"Taniguchi","year":"2013","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.bbr.2019.112119_bib0320","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.brainres.2007.12.033","article-title":"Magnesium exerts both preventive and ameliorating effects in an in vitro rat Parkinson disease model involving 1-methyl-4-phenylpyridinium (MPP+) toxicity in dopaminergic neurons","volume":"1197","author":"Hashimoto","year":"2008","journal-title":"Brain Res."},{"year":"2011","series-title":"Magnesium in Parkinson\u2019s disease: an update in clinical and basic aspects","author":"Oyanagi","key":"10.1016\/j.bbr.2019.112119_bib0325"},{"key":"10.1016\/j.bbr.2019.112119_bib0330","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0166-2236(88)90194-4","article-title":"Multiple types of neuronal calcium channels and their selective modulation","volume":"11","author":"Tsien","year":"1988","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbr.2019.112119_bib0335","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1523\/JNEUROSCI.19-15-06348.1999","article-title":"L-Type Ca(2+) channels are essential for glutamate-mediated CREB phosphorylation and c-fos gene expression in striatal neurons","volume":"19","author":"Rajadhyaksha","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2019.112119_bib0340","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1254\/jjp.80.351","article-title":"Role of glutamate receptors and voltage-dependent calcium channels in glutamate toxicity in energy-compromised cortical neurons","volume":"80","author":"Kimura","year":"1999","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.bbr.2019.112119_bib0345","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1006\/exer.2000.0968","article-title":"Voltage-dependent calcium channels in the rat retina: involvement in NMDA-stimulated influx of calcium","volume":"72","author":"Melena","year":"2001","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.bbr.2019.112119_bib0350","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.neuint.2016.07.003","article-title":"Nimodipine, an L-type calcium channel blocker attenuates mitochondrial dysfunctions to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice","volume":"99","author":"Singh","year":"2016","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbr.2019.112119_bib0355","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00394-002-0376-0","article-title":"Protective effect of calcium deficiency on the inflammatory response in magnesium-deficient rats","volume":"41","author":"Bussi\u00e8re","year":"2002","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.bbr.2019.112119_bib0360","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1139\/y87-120","article-title":"Mg2+-Ca2+ interaction in contractility of vascular smooth muscle: Mg2+ versus organic calcium channel blockers on myogenic tone and agonist-induced responsiveness of blood vessels","volume":"65","author":"Altura","year":"1987","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.bbr.2019.112119_bib0365","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1751-7176.2011.00538.x","article-title":"The role of magnesium in hypertension and cardiovascular disease","volume":"13","author":"Houston","year":"2011","journal-title":"J. Clin. Hypertens. Greenwich (Greenwich)"},{"key":"10.1016\/j.bbr.2019.112119_bib0370","doi-asserted-by":"crossref","first-page":"9023","DOI":"10.1523\/JNEUROSCI.0918-12.2012","article-title":"Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors","volume":"32","author":"Anzalone","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2019.112119_bib0375","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.tins.2012.06.008","article-title":"Striatal microcircuitry and movement disorders","volume":"35","author":"Gittis","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbr.2019.112119_bib0380","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/mds.25107","article-title":"Tardive dyskinesia is caused by maladaptive synaptic plasticity: a hypothesis","volume":"27","author":"Teo","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2019.112119_bib0385","doi-asserted-by":"crossref","DOI":"10.1017\/S1092852912000752","article-title":"New insights into the mechanism of drug-induced dyskinesia","author":"Loonen","year":"2013","journal-title":"CNS Spectr."},{"key":"10.1016\/j.bbr.2019.112119_bib0390","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.neuropharm.2014.02.005","article-title":"The potency and efficacy of anticholinergics to inhibit haloperidol-induced catalepsy in rats correlates with their rank order of affinities for the muscarinic receptor subtypes","volume":"81","author":"Erosa-Rivero","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2019.112119_bib0395","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.expneurol.2016.09.009","article-title":"Striatal cholinergic interneurons and D2 receptor-expressing GABAergic medium spiny neurons regulate tardive dyskinesia","volume":"286","author":"Bordia","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbr.2019.112119_bib0400","first-page":"1079","article-title":"Magnesium sulfate ameliorates cerebral ischemia reperfusion injury via interfering with inflammatory and oxidative pathways","volume":"2","author":"Hadi","year":"2014","journal-title":"Am. J. Biomed."},{"key":"10.1016\/j.bbr.2019.112119_bib0405","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1471-4159.1998.70010077.x","article-title":"The effect of magnesium on oxidative neuronal injury in vitro","volume":"70","author":"Regan","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2019.112119_bib0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.07.014","article-title":"Nifedipine and nimodipine protect dopaminergic substantia nigra neurons against axotomy-induced cell death in rat vibrosections via modulating inflammatory responses","volume":"1581","author":"Daschil","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2019.112119_bib0415","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s12640-012-9309-8","article-title":"Nifedipine prevents Iron accumulation and reverses iron-overload-Induced dopamine neuron degeneration in the substantia nigra of rats","volume":"22","author":"Ma","year":"2012","journal-title":"Neurotox. Res."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432819301494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432819301494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:12:53Z","timestamp":1759065173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432819301494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":83,"alternative-id":["S0166432819301494"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2019.112119","relation":{},"ISSN":["0166-4328"],"issn-type":[{"type":"print","value":"0166-4328"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of magnesium supplementation and L-type calcium channel blocker on haloperidol-induced movement disturbances","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2019.112119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112119"}}